Welcome to HealthyDogPetCo Blog

Sitemap xml

Free PMC article. No abstract available.

. Zhang W, et al. N Engl J Med. 2021 Aug 30. doi: 10.1056/NEJMoa2111437. Online ahead of print. N Engl J Med. 2021. PMID: 34491661 . Nature. 2021 Sep;597(7877):561-565. doi: 10.1038/s41586-021-03887-4. Epub 2021 Sep 8. Nature. 2021. PMID: 34497418
. Anderson-Baucum E, et al. Cell Metab. 2021 Sep 7;33(9):1883-1893.e7. doi: 10.1016/j.cmet.2021.08.003. Cell Metab. 2021. PMID: 34496231 .
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. . Free PMC article.
.
Tumor-induced disruption of the blood-brain barrier promotes host death.
Kim J, Chuang HC, Wolf NK, Nicolai CJ, Raulet DH, Saijo K, Bilder D. Kim J, et al.

top
top
Page
Menu
News
top
Page
Menu
News
Home Print viewSitemap
 
top
Page
Menu
News